1-4 of 4
Ryu Kasai, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pre-Analysis for Hemostatic Effect of Bypassing Agents in Hemophilia a Patients with Inhibitors Under the Emicizumab Prophylaxis By Global Assays

Shoko Furukawa, MD, Keiji Nogami, MD PhD, Tomoko Matsumoto, PhD, Ryu Kasai, MSc, Midori Shima, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3793.
https://doi.org/10.1182/blood-2018-99-114355
Published: 2018
Journal Articles

A Novel Hemostatic Monitoring System Convertible to FVIII Activity Based on Non-Activated ROTEM (NATEM) for Hemophilia a Patients during Emicizumab Prophylaxis

Koji Yada, MD PhD, Keiji Nogami, MD PhD, Ryu Kasai, MSc, Midori Shima, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3782.
https://doi.org/10.1182/blood-2018-99-117877
Published: 2018
Journal Articles

Clinical Course and Management of Surgical Emergency in a Severe Hemophilia a Patient Under Weekly Subcutaneous Administration of a Bispecific Antibody to Factors IXa and X (ACE910)

Takeshi Kanematsu, MD, Nobuaki Suzuki, MD PhD, Naomi Sanda, MSc, Mika Ogawa, MD, Mayuko Kishimoto, MD PhD, Atsuo Suzuki, PhD, Hitoshi Kiyoi, MD PhD, Ryu Kasai, MSc, Tadashi Matsushita, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1099.
https://doi.org/10.1182/blood.V126.23.1099.1099
Published: 2015
Journal Articles

Enhanced Global Hemostatic Potentials with a Bispecific Antibody to Factors IXa and X (ACE910) in the Whole Blood By Rotation Thromboelastometry (ROTEM)

Koji Yada, MDPhD, Keiji Nogami, MD PhD, Yasuaki Shida, MD PhD, Masahiro Takeyama, MD PhD, Ryu Kasai, MSc, Midori Shima, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3503.
https://doi.org/10.1182/blood.V126.23.3503.3503
Published: 2015